Our study not only unravels that diabetes aggravates atherosclerosis at least partially via decreasing MerTK expression and thus efferocytosis in macrophages, but also indicates that the HMNV-based MerTK delivery could be a promising therapeutic approach. Here, MERTK is linked to atherosclerosis.